Filing Details
- Accession Number:
- 0001209191-19-003415
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-01-11 16:18:29
- Reporting Period:
- 2019-01-09
- Accepted Time:
- 2019-01-11 16:18:29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1645113 | Novocure Ltd | NVCR | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1654363 | J. Michael Ambrogi | C/O Novocure Inc. 20 Valley Stream Parkway, Suite 300 Malvern PA 19355 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2019-01-09 | 75,000 | $14.37 | 221,558 | No | 4 | M | Direct | |
Ordinary Shares | Disposition | 2019-01-09 | 75,000 | $40.00 | 146,558 | No | 4 | S | Direct | |
Ordinary Shares | Acquisiton | 2019-01-09 | 25,000 | $11.46 | 171,558 | No | 4 | M | Direct | |
Ordinary Shares | Disposition | 2019-01-09 | 25,000 | $40.00 | 146,558 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Ordinary Shares | Options to Buy Ordinary Shares | Acquisiton | 2019-01-09 | 75,000 | $0.00 | 75,000 | $14.37 |
Ordinary Shares | Options to Buy Ordinary Shares | Acquisiton | 2019-01-09 | 25,000 | $0.00 | 25,000 | $11.46 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
92,321 | 2025-02-23 | No | 4 | M | Direct | |
16,274 | 2026-02-24 | No | 4 | M | Direct |
Footnotes
- These shares were acquired pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi.
- These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi.
- Fully vested as of the date hereof.